You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信立泰(002294.SZ):S086完成慢性心衰適應症Ⅲ期臨牀試驗首例受試者入組
格隆匯 06-23 16:53

格隆匯6月23日丨信立泰(002294.SZ)公佈,近日,公司自主研發的S086片(項目代碼:S086)治療射血分數減少的慢性心衰(HFrEF)適應症已完成Ⅲ期臨牀首例受試者入組。後續將繼續按照Ⅲ期臨牀試驗方案開展臨牀工作。

S086是一種血管緊張素II受體-腦啡肽酶雙重抑制劑,目標適應症為高血壓和慢性心衰(HFrEF),現均處於Ⅲ期臨牀階段。S086由公司自主創新研發,是全球第二個進入臨牀的ARNi類小分子化學藥物,其藥物相互作用風險小,安全性好,對心、腎等靶器官均有保護作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account